14
Participants
Start Date
February 28, 2007
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
Bortezomib
1.0 mg/m\^2 by Vein Over 5 Seconds on Days 1 and 4
Carboplatin
5 AUC by Vein Over 1 Hour On Day 1
Etoposide
100 mg/m\^2 By Vein Over 2 Hours On Days 1-3
Ifosfamide
5 Gm/m\^2 By Vein Continuous Infusion Over 24 Hours On Day 1
Mesna
5 mg/m\^2 IV continuous Infusion over 24 Hours On Day 1; 2 Gm/m\^2 IV continuous infusion over 12 hours starting after completion of Ifosfamide + Mesna 24 hour continuous infusion
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Millennium Pharmaceuticals, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER